Safe Prenatal Screening for Fetal Health Risks
Essential Prenatal Screening for Common Chromosomal Conditions
DNA GTx’s NIPT Basic analyzes fetal cell free DNA circulating in the mother's blood to screen for the three major autosomal aneuploidies: Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome). This provides highly accurate screening results as early as 10 weeks of gestation, without revealing fetal sex. It is designed for expectant mothers seeking essential chromosomal risk information with minimal intervention and no risk to the fetus.
Who is this Test for
- Pregnant individuals who want early, accurate, and safe information about their baby’s chromosomal condition
- Those at any age or risk level, including younger mothers
- Women who prefer minimal testing or wish to avoid unnecessary invasive procedure
What it Screens for
- Autosomal Aneuploidies:
Trisomy 21 (Down syndrome)
- Down syndrome occurs when there's an extra copy of chromosome 21, leading to characteristic physical features and varying degrees of developmental delay.
Trisomy 18 (Edwards syndrome)
- Edwards syndrome occurs when there is an extra chromosome 18, leading to serious health challenges and growth delays.
Trisomy 13 (Patau syndrome)
- Patau syndrome occurs when there is an extra chromosome 13, resulting in serious health challenges affecting growth, development, and organ function.
- Does not screen for sex chromosome aneuploidies or determine fetal sex
Key Benefits
- Minimally Invasive & Safe: Requires only a maternal blood sample—no risk to mother or baby
- Early Detection: Available from as early as 10 weeks of pregnancy
- High Accuracy: Reliable results for common chromosomal conditions
Turn Around Time
- 10 Days
How it Works
Step 1: Maternal Blood Sample Collection
- A blood sample is taken from the expectant mother.
- This sample contains cfDNA from both mother and baby.
Step 2: cfDNA Extraction
- The cfDNA is carefully separated from the rest of the blood.
- These tiny DNA fragments can reveal genetic changes or risks.
Step 3: Library Preparation
- The cfDNA is prepared so it can be read by our sequencing machines.
- We add special tags and focus on the most important parts of your cfDNA.
Step 4: Whole Genome Sequencing
- Advanced sequencing reads the entire genome at high resolution.
- Provides a comprehensive view of genetic information from cfDNA.
Step 5: Data Analysis
- Our proprietary software (D-KRYPT) helps us understand what the DNA changes mean.
- The results are derived from trusted medical databases.
Step 6: Personalized Patient Report
- You got a clear, easy-to-read report with the most important findings.
- Your doctor uses the report to guide clinical decisions and care during pregnancy.
Oncology Test Panels
Séquençage clinique
Solutions for Researchers
Prise en charge prénatale
Médecine régénérative
Healthcare
Agriculture
Bring Peace of Mind to Every Pregnancy
Partner with us to deliver reliable results and greater confidence to your patients — with a fast 10 day turnaround and expert support at every step.
*All information is handled with strict confidentiality.
Start Your Pregnancy Journey With Confidence
Our NIPT Basic screens for the three most common chromosomal conditions — Down syndrome, Edwards syndrome, and Patau syndrome — as early as 10 weeks into pregnancy.
*All information is handled with strict confidentiality.
